Modification of the crystal habit of celecoxib for improved processability.
Crystallization is often used in the pharmaceutical industry for purification and isolation of drugs, and also as a means of generating polymorphs or isomorphs. The aim of this study was to investigate the role of extrinsic crystallization parameters on the crystallized product, with special emphasis on improving the mechanical properties of acicular celecoxib. Celecoxib isomorphs were prepared using different techniques (solvent crystallization and vapour diffusion) and crystallization conditions (solvents, stirring, degree of supersaturation, crystallization temperature and seeding). Powder X-ray diffractometry, spectroscopic and thermal methods were used to investigate physical characteristics of crystals. Growth kinetics and aggregation dynamics of crystallization in polar and non-polar solvents were simulated using a dynamic light scattering method. The quick appearance of broad peaks over the range of 10-8000 nm in chloroform during crystallization simulation studies indicated faster aggregation in non-polar solvents. Aspect ratio, flow, compressibility and surface area of recrystallized products were also determined. Surface topography was determined by atomic force microscopy and the lath-shaped crystals (aspect ratio of 2-4) exhibited a roughness index of 1.79 in comparison with 2.92 for needles. Overall, the lath-shaped isomorphs exhibited improved flow and better compressibility.
Banga
Sheere
S
Department of Pharmaceutical Technology (Formulations), National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S.A.S. Nagar, Punjab - 160 062, India.
Chawla
Garima
G
Varandani
Deepak
D
Mehta
B R
BR
Bansal
Arvind K
AK
D002152:Calorimetry, Differential Scanning; D000068579:Celecoxib; D003460:Crystallization; D052246:Cyclooxygenase 2 Inhibitors / Q000737:chemistry*; D004058:Diffusion; D018625:Microscopy, Atomic Force; D011720:Pyrazoles / Q000737:chemistry*; D012212:Rheology; D012995:Solubility; D012997:Solvents / Q000737:chemistry; D013449:Sulfonamides / Q000737:chemistry*; D014961:X-Ray Diffraction
D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D012997:Solvents; D013449:Sulfonamides; D000068579:Celecoxib